JPRN-jRCT2080220565未知3 期
A Multicenter, Open-label Study of Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis
Abbott Japan Co., Ltd.0 个研究点目标入组 25 人开始时间: 2008年6月10日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 4age old 至 <= 17age old（—）
- 性别
- All
入选标准
- •Subjects who have a diagnosis of Polyarticular JRA by the ACR criteria.
排除标准
- •Subject who is considered by the investigator, for any reason, to be an unsuitable candidate for the study.
研究者
相似试验
未知
3 期
A Multi-Center, Open-Labeled Study of Adalimumab in Japanese Subjects with Active Ankylosing SpondylitisAnkylosing SpondylitisJPRN-jRCT2080220558Abbott Japan Co., Ltd.30
尚未招募
不适用
Adalimumab multicenter cohort study of the effectiveness for patients with Ulcerative colitisulcerative colitisJPRN-UMIN000029030Sapporokosei general hospital100
已完成
3 期
Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)Generalized Pustular Psoriasis (GPP)AdalimumabJapaneseNCT02533375AbbVie10
已完成
2 期
Evaluating the effects of Adalimumab in patients with acute respiratory distress syndrome caused by COVID-19IRCT20151227025726N23Shahid Beheshti University of Medical Sciences60
已完成
2 期
Adalimumab effectiveness in COVID-19COVID-19.C0VID-19U07.1IRCT20150303021315N22Tehran University of Medical Sciences40